Indoco Remedies Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is METOPROLOL SUCCINATE USP, with a corresponding US DMF Number 34890.
Remarkably, this DMF maintains an Active status since its submission on September 24, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 06, 2020, and payment made on September 22, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II